Renato Simões Gaspar1, Plinio M Ferreira2, Joanne L Mitchell3, Giordano Pula4, Jonathan M Gibbins3. 1. Institute for Cardiovascular and Metabolic Research, School of Biological Sciences, University of Reading, Reading, UK. Electronic address: renatosgaspar@gmail.com. 2. National Heart and Lung Institute, Imperial College London, London, UK. 3. Institute for Cardiovascular and Metabolic Research, School of Biological Sciences, University of Reading, Reading, UK. 4. University Medical Center Eppendorf Hamburg, Institute for Clinical Chemistry and Laboratory Medicine, Hamburg, Germany.
Abstract
BACKGROUND: Platelets release platelet-derived extracellular vesicles (PDEVs) upon activation - in a process that is regulated by generation of reactive oxygen species (ROS). Platelet NADPH oxidase-1 (Nox-1) contributes to ROS generation and thrombus formation downstream of the collagen receptor GPVI. OBJECTIVES: We aimed to investigate whether PDEVs contain Nox-1 and whether this is relevant for PDEV-induced platelet activation. METHODS: PDEVs were isolated through serial centrifugation after platelet activation with thrombin receptor agonist TRAP-6 (activated PDEVs) or in the absence of agonist (resting PDEVs). The physical properties of PDEVs were analyzed through nanoparticle tracking analysis. Nox-1 levels, fibrinogen binding and P-selectin exposure were measured using flow cytometry, and protein levels quantified by immunoblot analysis. ROS were quantified using DCF fluorescence and electron paramagnetic resonance. RESULTS: Nox-1 was found to be increased on the platelet outer membrane upon activation and was present in PDEVs. PDEVs induced platelet activation, while co-addition of GPVI agonist collagen-related peptide (CRP) did not potentiate this response. PDEVs were shown to be able to generate superoxide in a process at least partially mediated by Nox-1, while Nox-1 inhibition with ML171 (also known as 2-APT) did not influence PDEV production. Finally, inhibition of Nox-1 abrogated PDEV-mediated platelet activation. CONCLUSIONS: PDEVs are able to generate superoxide, bind to and activate platelets in a process mediated by Nox-1. These data provide novel mechanisms by which Nox-1 potentiates platelet responses, thus proposing Nox-1 inhibition as a feasible strategy to treat and prevent thrombotic diseases.
BACKGROUND: Platelets release platelet-derived extracellular vesicles (PDEVs) upon activation - in a process that is regulated by generation of reactive oxygen species (ROS). Platelet NADPH oxidase-1 (Nox-1) contributes to ROS generation and thrombus formation downstream of the collagen receptorGPVI. OBJECTIVES: We aimed to investigate whether PDEVs contain Nox-1 and whether this is relevant for PDEV-induced platelet activation. METHODS: PDEVs were isolated through serial centrifugation after platelet activation with thrombin receptor agonist TRAP-6 (activated PDEVs) or in the absence of agonist (resting PDEVs). The physical properties of PDEVs were analyzed through nanoparticle tracking analysis. Nox-1 levels, fibrinogen binding and P-selectin exposure were measured using flow cytometry, and protein levels quantified by immunoblot analysis. ROS were quantified using DCF fluorescence and electron paramagnetic resonance. RESULTS:Nox-1 was found to be increased on the platelet outer membrane upon activation and was present in PDEVs. PDEVs induced platelet activation, while co-addition of GPVI agonist collagen-related peptide (CRP) did not potentiate this response. PDEVs were shown to be able to generate superoxide in a process at least partially mediated by Nox-1, while Nox-1 inhibition with ML171 (also known as 2-APT) did not influence PDEV production. Finally, inhibition of Nox-1 abrogated PDEV-mediated platelet activation. CONCLUSIONS: PDEVs are able to generate superoxide, bind to and activate platelets in a process mediated by Nox-1. These data provide novel mechanisms by which Nox-1 potentiates platelet responses, thus proposing Nox-1 inhibition as a feasible strategy to treat and prevent thrombotic diseases.
Authors: T Seno; N Inoue; D Gao; M Okuda; Y Sumi; K Matsui; S Yamada; K I Hirata; S Kawashima; R Tawa; S Imajoh-Ohmi; H Sakurai; M Yokoyama Journal: Thromb Res Date: 2001-09-01 Impact factor: 3.944
Authors: Vijay K Sonkar; Rahul Kumar; Melissa Jensen; Brett A Wagner; Anjali A Sharathkumar; Francis J Miller; MaryBeth Fasano; Steven R Lentz; Garry R Buettner; Sanjana Dayal Journal: Blood Adv Date: 2019-04-23
Authors: Myriam Chimen; Aigli Evryviadou; Clare L Box; Matthew J Harrison; Jon Hazeldine; Lea H Dib; Sahithi J Kuravi; Holly Payne; Joshua M J Price; Dean Kavanagh; Asif J Iqbal; Sian Lax; Neena Kalia; Alex Brill; Steve G Thomas; Antonio Belli; Nicholas Crombie; Rachel A Adams; Shelley-Ann Evans; Hans Deckmyn; Janet M Lord; Paul Harrison; Steve P Watson; Gerard B Nash; G Ed Rainger Journal: Haematologica Date: 2019-08-29 Impact factor: 9.941
Authors: Dina Vara; Anuradha Tarafdar; Meral Celikag; Daniela Patinha; Christina E Gulacsy; Ellie Hounslea; Zach Warren; Barbara Ferreira; Maarten P Koeners; Lorenzo Caggiano; Giordano Pula Journal: FASEB J Date: 2020-08-26 Impact factor: 5.191
Authors: Jianlin Qiao; Jane F Arthur; Elizabeth E Gardiner; Robert K Andrews; Lingyu Zeng; Kailin Xu Journal: Redox Biol Date: 2017-09-08 Impact factor: 11.799
Authors: P M Ferreira; E Bozbas; S D Tannetta; N Alroqaiba; R Zhou; J T B Crawley; J M Gibbins; C I Jones; J Ahnström; P Yaqoob Journal: Sci Rep Date: 2020-10-22 Impact factor: 4.379
Authors: Wenpeng Zhao; Fumeng He; Herman W Barkema; Siyu Xu; Jian Gao; Gang Liu; Zhaoju Deng; Muhammad Shahid; Yuxiang Shi; John P Kastelic; Bo Han Journal: Vet Res Date: 2021-12-11 Impact factor: 3.683